✦ LIBER ✦

Reduced Circulating miR-15b Is Correlated with Phosphate Metabolism in Patients with End-Stage Renal Disease on Maintenance Hemodialysis

✍ Scribed by Wang, Honglei; Peng, Wujian; Ouyang, Xin; Dai, Yong

Book ID: 125843648
Publisher: Informa plc
Year: 2012
Tongue: English
Weight: 257 KB
Volume: 34
Category: Article
ISSN: 0886-022X
DOI: 10.3109/0886022X.2012.676491

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Detection of circulating antierythropoie

Detection of circulating antierythropoietin antibodies in patients with end stage renal disease on regular hemodialysis

✍ M. M. EL-DIN; F. M. ATTIA; S. M. LABIB; W. OMAR 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

Effect of hemodialysis on circulating cy

Effect of hemodialysis on circulating cystatin c levels in patients with end stage renal disease

✍ N. Krishnamurthy; K. Arumugasamy; U. Anand; C. V. Anand; V. Aruna; G. Venu; R. G 📂 Article 📅 2010 🏛 Association of Clinical Biochemistry of India 🌐 English ⚖ 112 KB

Spironolactone Use in Heart Failure Pati

Spironolactone Use in Heart Failure Patients With End-Stage Renal Disease on Hemodialysis: Is It Safe?

✍ Doson Chua; Anita Lo; Chris Lo 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB

Prevalence of circulating CD4+CD28null T

Prevalence of circulating CD4+CD28null T cells is associated with early atherosclerotic damage in patients with end-stage renal disease undergoing hemodialysis

✍ Zhiping Sun; Hong Ye; Bing Tang; Xia Shen; Xiaochun Wu; Hua Zhong; Weizong Song 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 625 KB

900 TELAPREVIR OR BOCEPREVIR THERAPY IN

900 TELAPREVIR OR BOCEPREVIR THERAPY IN CHRONIC HEPATITIS C PATIENTS WITH END STAGE RENAL DISEASE ON HEMODIALYSIS IS SAFE, TOLERABLE AND FEASIBLE

✍ Sclair, S.; Patel, A.; Junaidi, O.; Copado, V.; Martin, P.; Rudraraju, M.; Bhami 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 222 KB